Essentia BioSciences LTD is an **innovation company** in the **biotechnology** and **pharmaceutical** industries, focusing on iPSC therapy development and utilizing CRISPR technology. Founded in **2021**, the company is at the forefront of developing iPSC derived cell therapies with gene-editing technology. The latest milestone for Essentia BioSciences LTD is the **Angel Round investment** on **24 October 2023**, with notable investors including **Haitang Fund**, **China Singapore Airlines Capital**, **Beijing Molecular Technology**, **BioVenture**, and **Yiyuan Investment**. This latest investment signifies confidence in the company's potential and strategic vision.
General Information
Get notified when Essentia BioSciences LTD moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Essentia BioSciences LTD
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Essentia BioSciences LTD
Taxonomy: Innovation, iPSC therapy, CRISPR technology, Cell therapies, Gene-editing, Stem cell technology, Regenerative medicine, Medical innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Angel Round | •••••• | 5 |
|
24 Oct 2023 |
Essentia BioSciences LTD Alternatives & Competitors
Pioneering the future of human-derived immune cell technology with proprietary innovations since 201...
Nature gave us the parts. We provide the blueprints.
FAQ About Essentia BioSciences LTD
Don't just browse. Track.
Signal Tracker monitors Essentia BioSciences LTD and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.